ArticleImmunity, inflammation and disease2022

BMS-202, a PD-1/PD-L1 inhibitor, decelerates the pro-fibrotic effects of fibroblasts derived from scar tissues via ERK and TGFβ1/Smad signaling pathways.

Yuanyuan Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.